このエントリーをはてなブックマークに追加
ID 13224
Eprint ID
13224
FullText URL
Thumnail 119_293.pdf 291 KB
Title Alternative
III Surgical treatment of lung cancer according to evidence-based clinical practice guidelines
Author
Sano, Yoshifumi
Keywords
非小細胞肺癌
外科的治療
胸腔鏡下手術
術後治療
術前導入療法
Note
特集 がんの標準的治療
Published Date
2008-01-04
Publication Title
岡山医学会雑誌
Publication Title Alternative
Journal of Okayama Medical Association
Volume
volume119
Issue
issue3
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
293
End Page
300
ISSN
00301558
NCID
AN00032489
Content Type
Journal Article
References
1) 日本肺癌学会編 : EBMの手法による肺癌診療ガイドライン2005年版. 日本肺癌学会編, 金原出版, 東京 (2005).
2) Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT : American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery : ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 132, 161-177.
3) Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K : American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II : ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 132, 234-242.
4) Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW : American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA : ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 132, 243-265.
5) ESMO : Minimum recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer. Ann Oncol (2005) 16, 28-29.
6) Depierre A, Lagrange JL, Theobald S, et al. : Summary report of the standards, options and recommendations for the management of patients with non-small-cell lung carcinoma. Br J Cancer (2003) 89, 35-49.
7) Scottish Intercollegiate Guidelines Network : Management of patients with lung cancer. 2005 Scottish Intercollegiate Guidelines Network, Edinburgh, Scotland (2007).
8) National Comprehensive Cancer Network : Clinical practice guidelines in oncology : non-small cell lung cancer. Available at : http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf (2007).
9) National Cancer Institute : Non-small cell lung cancer (PDQ) : treatment. Available at : www.cancer.gov. (2007).
10) Central European Cooperative Oncology Group : Consensus on medical treatment of non-small cell lung cancer. Lung Cancer (2002) 38, 3-7.
11) National Institute of Clinical Excellence (UK) : Lung cancer : clinical guideline 24. Available at : www.nice.org.uk. (2007).
12) Association of Community Cancer Centers : Oncology patient management guidelines, version 3.0 Association of Community Cancer Centers, Rockville, MD (2000).
13) British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party : Guidelines on the selection of patients with lung cancer for surgery. Thorax (2001) 56, 89-108.
14) 下方 薫, 蘇原泰則 : 1999年肺癌外科切除例の全国集計に関する報告. 肺癌 (2007) 47, 299-311.
15) Grunenwald D, Le Chevalier T : Stage IIIA category of non-small-cell lung cancer : a new proposal. J Natl Cancer Inst (1997) 89, 88-89.
16) Gawrychowski J, Gabriel A, Lackowska B : Heterogeneity of stage IIIA non-small cell lung cancers (NSCLC) and evaluation of late results of surgical treatment. Eur J Surg Oncol (2003) 29, 178-184.
17) Shepherd FA, Ginsberg RJ, Patterson GA, Evans WK, Feld R : A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study. J Thorac Cardiovasc Surg (1989) 97, 177-186.
18) Shields TW, Higgins GA Jr, Matthews MJ, Keehn RJ : Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg (1982) 84, 481-488.
19) Suzuki K, Tsuchiya R, Ichinose Y, Watanabe Y, Yasumitsu T, Ishizuka N : Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer : The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). Proc Am Soc Clin Oncol (2000) 19, 492.
20) Ginsberg RJ, Rubinstein LV : Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg (1995) 60, 615-622.
21) Kodama K, Doi O, Higashiyama M, Yokouchi H : Intentional limited resection for selected patients with T1N0M0 non-small cell lung cancer. J Thorac Cardiovasc Surg (1997) 114, 347-353.
22) Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R : Intentional limited pulmonary resection for peripheral T1N0M0 small-sized lung cancer. J Thorac Cardiovasc Surg (2003) 125, 924-928.
23) Martin-Ucar AE, Nakas A, Pilling JE, West KJ, Waller DA : A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg (2005) 27, 675-679.
24) Keenan RJ, Landreneau J, Maley Jr RH, Singh D, Macherey R, Bartley S : Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg (2004) 78, 228-233.
25) Okada M, Yoshikawa K, Hatta T, Tsubota N : Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg (2001) 71, 956-961.
26) Yoshikawa K, Tsubota N, Kodama K, Ayabe H, Taki T, Mori T : Prospective study of extended segmentectomy for small lung tumors : the final report. Ann Thorac Surg (2002) 73, 1055-1058.
27) Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N : Radical sublobar resection for small-sized non-small cell lung cancer : a multicenter study. J Thorac Cardiovasc Surg (2006) 132, 769-775.
28) Deslauriers J, Gregoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y : Sleeve lobectomy versus pneumonectomy for lung cancer : a comparative analysis of survival and sites or recurrences. Ann Thorac Surg (2004) 77, 1152-1156.
29) Fadel E, Yildizeli B, Chapelier AR, Dicenta I, Mussot S, Dartevelle PG : Sleeve lobectomy for bronchogenic cancers : factors affecting survival. Ann Thorac Surg (2002) 74, 851-858.
30) Mezzetti M, Panigalli T, Giuliani L, Raveglia F, Lo Giudice F, Meda S : Personal experience in lung cancer sleeve lobectomy and sleeve pneumonectomy. Ann Thorac Surg (2002) 73, 1736-1739.
31) Chunwei F, Weiji W, Xinguan Z, Qingzen N, Xiangmin J, Qingzhen Z : Evaluations of bronchoplasty and pulmonary artery reconstruction for bronchogenic carcinoma. Eur J Cardiothorac Surg (2003) 23, 209-213.
32) Paulson DL : Carcinomas in the superior pulmonary sulcus. J Thorac Cardiovasc Surg (1975) 70, 1095-1104.
33) Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH, Shulman L, Shepherd F, Deschamps C, Livingston RB, Gandara D : Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas : long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol (2007) 25, 313-318.
34) Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Johnson D, Goldberg M, Detterbeck F, Shepherd F, Burkes R, Winton T, Deschamps C, Livingston R, Gandara D : Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus : Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg (2001) 121, 472-483.
35) Izbicki JR, Passlick B, Karg O, Bloechle C, Pantel K, Knoefel WT, Thetter O : Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg (1995) 59, 209-214.
36) Wu Y, Huang ZF, Wang SY, Yang XN, Ou W : A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer (2002) 36, 1-6.
37) Keller SM, Adak S, Wagner H, Johnson DH : Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg (2000) 70, 358-365.
38) Bollen EC, van Duin CJ, Theunissen PH, vt Hof-Grootenboer BE, Blijham GH : Mediastinal lymph node dissection in resected lung cancer : morbidity and accuracy of staging. Ann Thorac Surg (1993) 55, 961-966.
39) Izbicki JR, Thetter O, Habekost M, Karg O, Passlick B, Kubuschok B, Busch C, Haeussinger K, Knoefel WT, Pantel K, et al. : Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer : a randomized controlled trial. Br J Surg (1994) 81, 229-235.
40) Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, Thetter O : Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer : results of a prospective randomized trial. Ann Surg (1998) 227, 138-144.
41) Feinstein AR, Sosin DM, Wells CK : The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med (1985) 312, 1604-1608.
42) Kirby TJ, Mack MJ, Landreneau RJ, Rice TW : Lobectomy—video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg (1995) 109, 997-1001.
43) Sugi K, Kaneda Y, Esato K : Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg (2000) 24, 27-30.
44) Craig SR, Leaver HA, Yap PL, Pugh GC, Walker WS : Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg (2001) 20, 455-463.
45) Mahtabifard A, DeArmond DT, Fuller CB, McKenna RJ Jr : Video-assisted thoracoscopic surgery lobectomy for stage I lung cancer. Thorac Surg Clin (2007) 17, 223-231.
46) Giudicelli R, Thomas P, Lonjon T, Ragni J, Morati N, Ottomani R, Fuentes PA, Shennib H, Noirclerc M : Video-assisted minithoracotomy versus muscle-sparing thoracotomy for performing lobectomy. Ann Thorac Surg (1994) 58, 712-717.
47) PORT Meta-analysis Trialists Group : Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev (2005) CD002142.
48) Non-small Cell Lung Cancer Collaborative Group : Chemotherapy in non-small cell lung cancer : a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ (1995) 311, 899-909.
49) Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, Ohta M ; Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy : A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med (2004) 350, 1713-1721.
50) Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, Wada H : Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol (2005) 23, 4999-5006.
51) Shields TW, Higgins GA Jr, Lawton R, Heilbrunn A, Keehn RJ. Preoperative x-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma. J Thorac Cardiovasc Surg (1970) 59, 49-61.
52) Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C ; French Thoracic Cooperative Group : Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol (2002) 20, 247-253.
53) Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M, et al. : A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst (1994) 86, 673-680.
54) Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J, Olazabal A, et al. : A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med (1994) 330, 153-158.
55) Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H ; Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group : A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg (2003) 125, 254-260.
56) Skarin A, Jochelson M, Sheldon T, Malcolm A, Oliynyk P, Overholt R, Hunt M, Frei E 3rd : Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer : long-term follow-up in 41 patients. J Surg Oncol (1989) 40, 266-274.
57) Taylor SG 4th, Trybula M, Bonomi PD, Faber LP, Lee MS, Reddy S, Maffey SC, Mathisen DJ, Jensik RJ, Kittle CF : Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer. Ann Thorac Surg (1987) 43, 87-91.
58) Faber LP, Kittle CF, Warren WH, Bonomi PD, Taylor SG 4th, Reddy S, Lee MS : Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg (1989) 47, 669-675.
59) Weiden PL, Piantadosi S : Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer : a phase II study of the Lung Cancer Study Group. J Natl Cancer Inst (1991) 83, 266-273.
60) Weitberg AB, Yashar J, Glicksman AS, Posner M, Cummings F, Browne M, Clark J, Calabresi P, Beitz J, Murray C : Combined modality therapy for stage IIIA non-small cell carcinoma of the lung. Eur J Cancer (1993) 29, 511-515.
61) Rusch VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R Jr, Livingston RB, Griffin BR, Benfield JR : Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. J Thorac Cardiovasc Surg (1993) 105, 97-104.
62) Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3 rd, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR, et al. : Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer : mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol (1995) 13, 1880-1892.
63) Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, et al. : Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer. Ann Thorac Surg (1995) 60, 586-591.
64) Mathisen DJ, Wain JC, Wright C, Choi N, Carey R, Hilgenberg A, et al. : Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer. J Thorac Cardiovasc Surg (1996) 111, 123-131.
65) Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, et al. : Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol (1997) 15, 712-722.
66) Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, et al. : Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer : mature results of a phase II trial. J Clin Oncol (1998) 16, 622-634.
67) Bedini AV, Tavecchio L, Palazzi M : Surgical results of maximal local-regional treatment (cisplatin-enhanced high-dose radiotherapy and adjuvant surgery) in initially non-resectable stage III lung cancer. Lung Cancer (2002) 35, 271-277.
68) Katayama H, Ueoka H, Kiura K, Tabata M, Kozuki T, Tanimoto M, et al. : Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer (2004) 90, 979-984.
69) Ichinose Y, Fukuyama Y, Asoh H, Ushijima C, Okamoto T, et al. : Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer. Ann Thorac Surg (2003) 76, 1810-1814.
70) Yasufuku K, Nakajima T, Chiyo M, Sekine Y, Shibuya K, Fujisawa T : Endobronchial ultrasonography : current status and future directions. J Thorac Oncol (2007) 2, 970-979.
71) Silvestri GA, Rivera MP : Targeted therapy for the treatment of advanced non-small cell lung cancer : a review of the epidermal growth factor receptor antagonists. Chest (2005) 128, 3975-3984.
72) 鶴尾 隆 : 治療の進歩 肺がん治療とテーラーメード治療. Annual Review 呼吸器 (2003) 2003, 260-266.
73) Schraube P, von Kampen M, Oetzel D, Sroka G, Wannenmacher M : The impact of 3-D radiotherapy planning after a pneumonectomy compared to a conventional treatment set-up. Radiother Oncol (1995) 37, 65-70.
74) Schulz-Ertner D, Tsujii H : Particle radiation therapy using proton and heavier ion beams. J Clin Oncol (2007) 25, 953-964.
75) Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L : Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol (2007) 25, 947-952.
76) Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, Yamada K, Araki T : Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer : updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol (2007) 2, 94-100.
77) Gejerman G, Mullokandov EA, Bagiella E, Blaivas A, Beitler JJ : Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension. Brachytherapy (2002) 1, 204-210.
78) Abbas G, Schuchert MJ, Pennathur A, Gilbert S, Luketich JD : Ablative treatments for lung tumors : radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin (2007) 17, 261-271.
79) Ahmed A, Littrup P : Percutaneous cryotherapy of the thorax : safety considerations for complex cases. AJR Am J Roentgenol (2006) 186, 1703-1706.
80) Usuda J, Kato H, Okunaka T, Furukawa K, Tsutsui H, Yamada K, Suga Y, Honda H, Nagatsuka Y, Ohira T, Tsuboi M, Hirano T : Photodynamic therapy (PDT) for lung cancers. J Thorac Oncol (2006) 1, 489-493.
language
日本語
Copyright Holders
岡山医学会
File Version
publisher
Refereed
True
DOI
Eprints Journal Name
joma